16-75223173-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.

The NM_001906.6(CTRB1):ā€‹c.269A>Gā€‹(p.Asp90Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000018 ( 0 hom., cov: 17)
Exomes š‘“: 0.000038 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CTRB1
NM_001906.6 missense

Scores

3
9
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.28
Variant links:
Genes affected
CTRB1 (HGNC:2521): (chymotrypsinogen B1) This gene encodes a member of the serine protease family of enzymes and forms a principal precursor of the pancreatic proteolytic enzymes. The encoded preproprotein is synthesized in the acinar cells of the pancreas and secreted into the small intestine where it undergoes proteolytic activation to generate a functional enzyme. This CTRB1 gene is located head-to-head with the related CTRB2 gene. Some human populations have an alternate haplotype which inverts a 16.6 Kb region containing portions of intron 1, exon 1, and the upstream sequence of the CTRB1 and CTRB2 genes. In this inversion haplotype exon 1 and flanking sequence is swapped in CTRB1 and CTRB2. This inversion is associated with differential gene expression and increased risk for chronic pancreatitis. The GRCh38 assembly represents the minor allele for SNP rs8048956 of the CTRB1 gene. SNP rs8048956 in intron 1 of the CTRB2 gene is diagnostic for this inversion. This CTRB1 gene encodes distinct isoforms, some or all of which may undergo similar processing to generate the mature protein. [provided by RefSeq, Jan 2021]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CTRB1NM_001906.6 linkuse as main transcriptc.269A>G p.Asp90Gly missense_variant 4/7 ENST00000361017.9 NP_001897.4 P17538
CTRB1NM_001329190.2 linkuse as main transcriptc.269A>G p.Asp90Gly missense_variant 4/6 NP_001316119.1 P17538

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CTRB1ENST00000361017.9 linkuse as main transcriptc.269A>G p.Asp90Gly missense_variant 4/71 NM_001906.6 ENSP00000354294.4 P17538
CTRB1ENST00000495583.1 linkuse as main transcriptc.341A>G p.Asp114Gly missense_variant 3/42 ENSP00000463301.1 J3QKZ2

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
2
AN:
111990
Hom.:
0
Cov.:
17
FAILED QC
Gnomad AFR
AF:
0.0000321
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000998
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000379
AC:
39
AN:
1028810
Hom.:
0
Cov.:
15
AF XY:
0.0000327
AC XY:
17
AN XY:
520220
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000511
Gnomad4 OTH exome
AF:
0.0000218
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000179
AC:
2
AN:
111990
Hom.:
0
Cov.:
17
AF XY:
0.00
AC XY:
0
AN XY:
52910
show subpopulations
Gnomad4 AFR
AF:
0.0000321
Gnomad4 AMR
AF:
0.0000998
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000843
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 14, 2024The c.269A>G (p.D90G) alteration is located in exon 4 (coding exon 4) of the CTRB1 gene. This alteration results from a A to G substitution at nucleotide position 269, causing the aspartic acid (D) at amino acid position 90 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.57
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Uncertain
0.57
D;.
Eigen
Benign
0.15
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.77
T;T
M_CAP
Pathogenic
0.44
D
MetaRNN
Uncertain
0.71
D;D
MetaSVM
Uncertain
0.70
D
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-5.4
D;.
REVEL
Uncertain
0.63
Sift
Uncertain
0.010
D;.
Sift4G
Benign
0.074
T;T
Polyphen
0.24
B;.
Vest4
0.28
MutPred
0.58
Loss of catalytic residue at D90 (P = 0.0959);.;
MVP
0.98
MPC
2.9
ClinPred
0.99
D
GERP RS
4.6
Varity_R
0.88
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1225332088; hg19: chr16-75257071; API